首页> 中文期刊> 《亚洲社会药学》 >The Status Quo and Countermeasures of“4+7”Quantity Purchase in China

The Status Quo and Countermeasures of“4+7”Quantity Purchase in China

         

摘要

Objective To understand the effectiveness and problems of centralized drug procurement in China by analyzing the implementation of the“4+7”pilot work for centralized drug procurement in China.Methods The current situation and existing problems of drug procurement in China were analyzed through the literature research method.Results and Conclusion At present,good social benefits have been achieved for China’s drug procurement through pilot projects in several cities,but there are some serious problems.The proposed countermeasures will help to improve the procurement of pharmaceuticals in China.

著录项

  • 来源
    《亚洲社会药学》 |2020年第2期|P.89-96|共8页
  • 作者单位

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 中国工业经济;
  • 关键词

    quantity procurement; 4+7; drug bidding;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号